SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $287M invested in SPDR S&P Pharmaceuticals ETF in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 6 closing their positions.
Holders
72
Holders Change
+7
Holders Change %
+10.77%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
13
Increased
25
Reduced
22
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
U
1
UBS
Zurich,
Switzerland
|
$24.5M |
| 2 |
2
Goldman Sachs
New York
|
$16.9M |
| 3 |
NCM
3
Niemann Capital Management
Stateline,
Nevada
|
$9.89M |
| 4 |
4
Morgan Stanley
New York
|
$58.4M |
| 5 |
5
LPL Financial
San Diego,
California
|
$12.6M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AAS
76
Annex Advisory Services
Brookfield,
Wisconsin
| – | – | -4,728 | Closed |
|
77
Invesco
Atlanta,
Georgia
| – | – | -2,780 | Closed |
|
|
ASN
78
Advisory Services Network
Atlanta,
Georgia
| – | – | -1,200 | Closed |
|